Health industries

  • Potential impacts to Pharma and Life Sciences companies of the new accounting definition of an "investment company"

    4/10/14 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Alert focuses on the key accounting considerations when assessing whether an entity is an investment company under the new accounting definition and provides illustrative examples.

  • Webcast
    Hot topics and technical updates impacting accounting and financial reporting for Healthcare, Higher Education and Not-for-Profit webcast – April 24, 2014

    4/9/14 | Healthcare

    This installment of PwC's Healthcare, Higher Education, and Not-for-Profit quarterly webcast series covers (1) recent developments related to the FASB/IASB convergence projects, (2) an update on FASB projects impacting not-for-profit entities, and (3) as a refresher we will talk about standards that will be effective this year.

  • Webcast
    Hot Topics in Healthcare Joint Ventures and Strategic Affiliations webcast – April 22, 2014

    4/9/14 | Healthcare

    Please join PwC for "Hot Topics in Healthcare Joint Ventures and Strategic Affiliations" as our tax specialists discuss some of the various tax issues that arise when forming such relationships.

  • Webcast
    Eliminate Cash Leakage with Oracle Advanced Financial Controls for Healthcare Providers - PwC and Oracle webcast - April 17, 2014

    4/2/14 | Risk Assurance

    PwC's Risk Assurance Group invites you to attend the Eliminate Cash Leakage with Oracle Advanced Financial Controls for Healthcare Providers webcast to learn how Oracle Advanced Financial Controls can provide a thorough financial controls solution for your organization.

  • Rx Marketplace Quarterly Newsletter

    3/27/14 | Pharmaceuticals & life science

    The PwC Rx Marketplace Quarterly features a wide range of financial reporting developments, accounting and tax developments, regulatory updates and general industry trends impacting the pharmaceutical and life sciences industry. Each quarterly also shares strategies that companies can use to unlock divestiture value, as well as links to publications and online resources. In the spotlight in this issue is our summary of the IPO market, which has seen its most robust year since 2007. We cover key metrics for the past year, assess the industry’s top registrants, and offer a snapshot of IPO activity during the first two months of 2014.

  • Pharmaceutical Commerce: Top health industry issues for life sciences in 2014

    3/25/14 | Pharmaceuticals & life science

    Pharmaceutical Commerce: Top health industry issues for life sciences in 2014

  • US health services deals insights: analysis and trends in US health services activity 2013 and 2014 outlook

    3/24/14 | Transaction services

    In 2013, the most notable deal activity was in the hospital sector. While hospital deal volume was down, hospital deal value increased from $1.9 billion in 2012 to $18.6 billion in 2013.

  • An HR perspective, The Future of Healthcare Benefits - Employers’ opportunity for strategic change in the new healthcare world

    3/13/14 | Human resource services

    PwC recently convened several roundtables of employers in New York, Chicago, and Atlanta to discuss health coverage at this pivotal moment. This thought leadership article highlights the conversations and results of the related survey.

  • Economic Impact of Trade Secret Theft

    2/25/14 | Forensic services

    News stories, international negotiations, and recent case law continue to demonstrate the importance of securing trade secrets as a means of ensuring prosperity for companies operating in the U.S. and abroad.

  • Overcoming challenges of leading innovation in medical technology and research in the global market

    2/25/14 | Forensic services

    Promoting healthcare solutions worldwide requires navigation of the complex and constantly changing landscape of US export control laws. How regulatory controls apply to medical devices, pharmaceuticals, and biotechnology products is unique, and understanding where and how to export these products is critical to competing in the global market. This piece discusses the effect of “dual use” controls, defense regulations, and OFAC sanctions on these products, and the risks and opportunities for this booming industry.

  • Distinguishing a Business from an Asset or a Group of Assets

    1/16/14 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Industry GAAP Alert focuses on the key accounting considerations when making this determination and provides illustrative examples.

  • Webcast
    Addressing the compensation and benefits challenges in a consolidating healthcare industry webcast – January 22, 2014

    1/9/14 | Human resource services

    The consolidation in the healthcare industry is creating new and bigger HR related challenges. As health systems redefine their brands and clarify their strategies in this time of convergence, hospital executives have new struggles to conquer, from evaluating merger candidates to integrating them (including the nuances of integrating physician practices), to delivering meaningful benefits in cost effective ways.

  • Healthcare provider: 2013 SEC comment letter trends

    1/6/14 | Health Research Institute

    To help registrants gain insight into the SEC’s current areas of interest, PwC analyzed comments released by the SEC staff to domestic large accelerated, accelerated and non-accelerated registrants within the healthcare provider industry during the three year period ended September 30, 2013.

  • Top health industry issues of 2014

    12/11/13 | Health Research Institute

    The 2014 Top Issues report examines the shifting healthcare landscape and offers insights on how to survive rising expectations and tough competition.

  • Video: Healthcare costs and the Affordable Care Act

    12/10/13 | Assurance services

    PwC's Jay Seliber, Michael Thompson and Ken Stoler discuss the Affordable Care Act and accounting implications for retiree medical plans.

  • Webcast
    Healthcare, Higher Education and Nonprofit Organizations: A Review of 2013 and a Look Ahead to 2014 – December 19, 2013

    12/3/13 | Healthcare

    Our tax specialists will highlight the past year, review the impact of the Affordable Care Act (ACA) on employers in 2014 and beyond, review developments in information reporting, provide an outlook of potential future initiatives from the Internal Revenue Service, and other issues impacting healthcare providers, universities and other tax-exempt organizations.

  • Q3 2013 US health services deals insights

    11/25/13 | Transaction services

    The third quarter of 2013 realized a slight uptick over the prior two quarters in the volume of healthcare services deals with 138 total transactions. However, the value of the dealsannounced in Q3 2013, $15.8 billion, was up 35% over the second quarter. In both volume and value, the year-to-date period for 2013 continues to lag the same period in 2012 with volume down 4.6% and value down 25%.

  • Accounting guides
    US GAAP: Issues and solutions for pharmaceuticals and life sciences industry

    11/20/13 | Pharmaceuticals & life science

    This publication highlights factors the industry should consider and provides guidance on the most pertinent accounting solutions under US GAAP. The solutions presented are meant to provide a framework for determining the appropriate accounting answer for general solutions.

  • Customer experience in the pharmaceutical sector: Getting closer to the patient

    11/19/13 | Pharmaceuticals & life science

    As patients exert greater control over their healthcare, drug makers need to master the complexities of consumer behavior to demonstrate value in the new health economy. Consumers are willing to offer feedback that informs who they are, how they behave and how existing biases impact their behavior. Drug makers that tap into this feedback will reach a new level of success.

  • Flexible spending accounts can now allow carryover of up to $500 to following year

    11/6/13 | Human resource services

    IRS has amended its rules for healthcare flexible spending accounts to permit carry over up to $500 per plan year rather than forfeit all unused funds

  • Pharmaceutical and Life Sciences: 2013 SEC comment letter trends

    10/23/13 | Health Research Institute

    Pharmaceutical and Life Sciences - 2013 SEC comment letter trend compiles and analyzes the SEC staff’s comment letters issued over the past few years to registrants across different sectors within the Pharmaceutical and Life Sciences industry and provides highlights surrounding current hot topics and sample comments.

  • HR Innovation Summer/Fall 2013

    10/17/13 | Human resource services

    HR Innovation offers advanced thinking about the challenges that should be uppermost on the minds and agendas of organizations and their Human Resources (HR) leaders. In this issue of HR Innovation, we focus on the continually changing HR landscape and what organizations need to do to take control of today’s opportunities and tomorrow’s decisions.

  • Webcast
    Hot topics and technical updates impacting accounting and financial reporting for Healthcare, Higher Education and Not-for-Profit – October 23, 2013

    10/16/13 | Healthcare

    This installment of PwC's Healthcare, Higher Education and Not-for-Profit quarterly webcast series covers FASB standard setting developments that have occurred since our July webcast. As always, the focus is on not-for-profit organizations that apply FASB standards, with an emphasis on healthcare and higher education institutions.

  • Contingent Consideration in a Business Combination

    10/16/13 | Pharmaceuticals & life science

    This Pharmaceutical and Life Sciences Industry Alert provides guidance on the accounting for contingent consideration arrangements in business combinations.

  • Medtech companies prepare for an innovation makeover

    10/10/13 | Health Research Institute

    The mere concept of innovation needs redefining in a health ecosystem that demands and rewards new models for delivering better care across a broader patient population at lower costs. Medtech companies must get ready to compete in this new environment or risk being displaced by ones that can show evidence their innovations achieve the same high clinical standards but are faster, better, cheaper, and more integrated into the care delivery continuum.

  • Accounting guides
    US GAAP: Issues and solutions for the medical technology industry

    9/26/13 | Healthcare

    This publication highlights factors the medical technology industry should consider and provides guidance on the most pertinent accounting solutions under US GAAP. The solutions presented are meant to provide a framework for determining the appropriate accounting answer for general solutions.

  • Affordable Care Act reporting requirements — IRS’ first pass

    9/24/13 | Human resource services

    Employers and issuers will have new IRS reporting obligations as key players in implementing ACA health coverage mandates.

  • No pre-tax reimbursement for individual insurance under ACA; employee assistance programs OK

    9/24/13 | Human resource services

    The Obama Administration has released guidance about how the ACA market reforms apply to HRAs and other employer reimbursement programs, health FSAs and EAPs.

  • DOL clarifies that no penalties apply for failure to provide ACA notices about exchanges

    9/24/13 | Human resource services

    In a recent FAQ, the DOL confirmed that employers won't be subject to any fine or penalty for failing to provide a ‘Notice of Coverage Options’ to employees.

  • Spotlight Lease Accounting: Transformational Change

    9/4/13 | Healthcare

    Included in this brief are next steps organizations should consider as well as an FAQs section and key contacts you may reach out to for additional follow up.

  • Q2 2013 US Health Services Deals Insights

    8/20/13 | Transaction services

    Q2 2013 continues the trends started in late 2012 and in Q1 2013 with both financial and strategic buyers exhibiting cautious behaviors across all sectors. Through Q2 2013, health services deal volume has increased 3.9% from 127 deals in Q1 2013 to 132 deals in Q2 2013. The value of these transactions has also increased 151% across the same periods.

  • PwC Saratoga 2013/2014 Human Capital Effectiveness Report: Trends for the Healthcare Provider Sector

    8/6/13 | PwC Saratoga

    As healthcare systems face increasing challenges related to implementation of the Affordable Care Act, talent will be a large focus to keep expenditures low and productivity high. HR will need to work to engage and retain their key employees – high performers and those within pivotal roles – to help brace for these changes.

  • 10Minutes
    10Minutes on drug value in the New Health Ecosystem

    7/31/13 | Pharmaceuticals & life science

    Pharmaceutical companies stand ready to be tested in a world where a drug’s success is more closely tied to its performance. The challenges mount with competition from generics and growing pressure to reduce costs. Now, insurers and integrated providers are driven by models that reward health outcomes and cost savings. For success, drug makers are exploring real-world evidence, new payment models, and the right partnerships.

  • In brief
    In brief: FASB finalizes standard deferring certain quantitative disclosures for nonpublic employee benefit plans (No. 2013-36)

    7/10/13 | Assurance services

    The FASB issued ASU 2013-09. It provides an indefinite deferral for certain quantitative fair value disclosures for nonpublic employee benefit plans.

  • Administration delays reporting, enforcement of employer mandate for 2014

    7/3/13 | Washington national tax services (WNTS)

    The Obama Administration has announced that there will be an additional year before the mandatory employer and insurer reporting requirements under the Affordable Care Act (ACA) begin, and, accordingly, a one-year delay in enforcement of the employer mandate until 2015.

  • Medical cost trend: Behind the numbers, 2014

    6/21/13 | Health Research Institute

    This PwC Health Research Institute (HRI) report looks at the projected increase in the cost of medical services for 2014. Medical cost trend is the primary factor in setting health insurance premiums.

  • PwC's 2013 Health and Well-being Touchstone Survey results

    6/19/13 | Human resource services

    PwC is pleased to announce the availability of our 2013 Health and Well-being Touchstone Survey. The 2013 survey data contains detailed benefits information provided by approximately 1,100 participating companies in 35 different industries across the nation.

  • New wellness regulations may cause headaches

    6/13/13 | Human resource services

    Starting in 2014, group health plans and insurers will be able to offer higher financial rewards to participants achieving healthy behaviors.

  • MoneyTreeTM venture capital funding: Capital crunch

    5/22/13 | Pharmaceuticals & life science

    The life sciences share of total venture funding declined from 28% during the last quarter of 2012 to 23% during the first quarter of 2013. Biotechnology, raising $875 million in 96 deals during the first quarter, placed a distant second in dollars raised behind software, which drew $2.3 billion in 329 deals.

  • Pharmaceutical and Life Sciences Deals Insights Quarterly

    5/20/13 | Transaction services

    Merger and acquisition deal value in the pharmaceutical and life sciences sector increased in the first quarter of 2013 relative to the first quarter of 2012. The pharmaceutical segment recorded the largest gains in deal value during the quarter on the strength of several large transactions.

  • ACA proposed regulations on minimum value, premium tax credits help employers with health plan duties for 2014

    5/20/13 | Human resource services

    The IRS issued proposed regulations under the ACA that will help employers to determine, disclose and report whether their health plans provide ‘minimum value.’

  • An HR perspective: Focusing on the future of healthcare benefits

    5/15/13 | Human resource services

    PwC recently convened several roundtables of employers in New York, Chicago, and Atlanta to discuss health coverage at this pivotal moment. This thought leadership article highlights the conversations and results of the related survey.

  • M&A snapshot
    We’re acquiring a company with significant in-process research and development (IPR&D) activities. What's next? (M&A snapshot)

    4/23/13 | Assurance services

    This edition of Mergers & acquisitions — a snapshot provides an overview of the accounting rules and a glimpse into some of the issues companies face in the accounting and valuation of acquired IPR&D.

  • 10Minutes
    10Minutes on investing in China's private healthcare system

    4/18/13 | Healthcare

    China recently introduced its 12th Five-Year Plan, which reinforces the government's commitment to easing ownership requirements. This 10Minutes discusses opportunities that private and foreign providers, payers, and investors can adopt to build a presence in China's growing healthcare market.

  • Medical device excise tax (updated March 28, 2013)

    3/29/13 | Pharmaceuticals & life science

    This edition of PwC's Pharmaceutical and Life Sciences Industry Alert reports that medical device manufacturers will need to begin accounting for this tax for all sales, other than tax free sales, beginning January 1, 2013 and will need to consider the impact of this tax on their 2013 results.

  • Potential Accounting Implications of Supreme Court Decision on the Affordable Care Act

    5/31/12 | Pharmaceuticals & life science

    The Supreme Court heard arguments concerning the Affordable Care Act in March 2012 and expects to issue its decision on the constitutionality of the Affordable Care Act by the end of June 2012. If the law should be invalidated by the Supreme Court, either in whole or in part, there could be significant accounting and financial reporting implications. This PwC Pharmaceutical and Life Sciences Industry Alert focuses on the potential accounting implications of the Supreme Court decision on the Affordable Care Act.

  • Greece Debt Restructuring

    4/9/12 | Pharmaceuticals & life science

    In February 2012, the Greek government announced a debt restructuring which required holders to exchange their two-year and three-year bonds, currently scheduled to mature in December 2012 and 2013, for new non-interest bearing government bonds with longer maturities and a reduced redemption value. This edition of PwC's Pharmaceutical and Life Sciences Industry Alert discusses why pharmaceutical companies will need to evaluate the debt restructuring in order to properly assess the accounting impact of this event.

  • Dataline / In depth
    Dataline (Supplement): Revenue from contracts with customers - Pharmaceutical and life sciences industry (No. 2011-35)

    12/1/11 | Assurance services

    The FASB and IASB released an updated exposure draft, Revenue from Contract with Customers, on November 14, 2011, and are requesting comments by March 13, 2012. In Dataline 2011-35, we share our analysis of and insight on the overall proposal. This industry supplement to Dataline 2011-35 provides specific examples and assessments of the potential affect of the updated proposal on the pharmaceutical and life sciences industry.